Circulation:V因子Leiden与动脉血栓形成事件风险的相关性

2020-08-11 MedSci原创 MedSci原创

鉴于凝血参与动脉粥样硬化斑块破裂后的血栓形成阶段,研究人员推测V因子Leiden可能是冠心病(CHD)患者发生血栓形成事件的一个较强的危险因素。本研究旨在评估V因子与动脉血栓形成的相关性。

目前缺乏V因子Leiden在高动脉血栓形成风险患者中的作用的研究。鉴于凝血参与动脉粥样硬化斑块破裂后的血栓形成阶段,研究人员推测V因子Leiden可能是冠心病(CHD)患者发生血栓形成事件的一个较强的危险因素。

Mahmoodi等进行了一项个体水平的Meta分析,纳入了25个前瞻性研究(18个队列、3个病例队列、4个随机试验),共包含69681位受试者,其中3190位(4.6%)位V因子Leiden的杂合或纯合突变携带者。

中位随访1-10.6年。共20个研究的61147位受试者和6849例事件被纳入主要预后分析。V因子Leiden与心肌梗死和CHD死亡的复合预后无关(风险比[HR] 1.03,95% CI 0.92-1.16,p=0.12)。亚组分析未见相关差异。与此类似,次要预后(包括卒中、冠脉重建、血管死亡和全因死亡率)的风险评估也几乎相同。

结论:在已确诊和治疗中的冠心病患者中,V因子Leiden与随后的动脉血栓形成事件和死亡率风险增加无关。

原始出处:

Bakhtawar K. Mahmoodi,et al. Association of Factor V Leiden With Subsequent Atherothrombotic Events. Circulation. 2020;142:546–555

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
    2020-08-11 ms8000001944926977

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
    2020-08-11 148a1681m56暂无昵称

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1709020, encodeId=8a0f1e09020a1, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 12:06:47 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837870, encodeId=be1c183e87040, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 21 14:06:47 CST 2020, time=2020-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536828, encodeId=657a153682819, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560179, encodeId=6eb715601e9cb, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566188, encodeId=0a6815661881a, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Aug 13 03:06:47 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807466, encodeId=8d8880e466fc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/174cd744042249989fd0a3eacc6c24e4/a84979f0d1834ebcb57d1eed97e617b3.jpg, createdBy=45d75410218, createdName=ms8000001944926977, createdTime=Tue Aug 11 12:57:45 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807464, encodeId=fdda80e464c1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80f15318171, createdName=148a1681m56暂无昵称, createdTime=Tue Aug 11 12:20:46 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807463, encodeId=8d7380e4633e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1BAAC01FD72610F8B5E43FA8CCF990A4/100, createdBy=50c12202766, createdName=百木~, createdTime=Tue Aug 11 12:20:16 CST 2020, time=2020-08-11, status=1, ipAttribution=)]
    2020-08-11 百木~

    学习了

    0

相关资讯

Eur Heart J:Alirocumab 对高龄冠心病患者预后的影响研究

降低低密度脂蛋白胆固醇(LDL-C)可降低心血管风险,而与年龄无关,但对老年患者来说,这一证据并不那么有力。

JACC:联合临床和基因风险评估可更好地预防冠心病

冠心病(CAD)的多基因危险度评分(PRS)确定高危人群更有可能从一级预防他汀类药物治疗中获益。本研究的目的旨在将多基因风险评估与基于指南的冠心病一级预防建议和管理模式相结合。

JACC:冠脉18F氟化钠的摄入可预测冠心病患者心梗风险

目前尚缺乏可靠的方法预测冠心病患者的心肌梗死,冠状动脉18F氟化钠(18F-NaF)正电子发射断层扫描(PET)可评估动脉粥样硬化活动。本研究旨在评估18F-NaF-PET是否能预测心肌梗死,并为目前

JACC:氟哌啶酮PET在冠心病诊断有良好的安全性和有效性

氟-18氟哌啶酮是一种新型的正电子发射断层扫描(PET)心肌灌注成像示踪剂。这项研究旨在评估氟吡哌酮PET与tech 99m标记的单光子发射计算机断层扫描SPECT在检测和评估冠状动脉疾病(CAD)方

Circulation:精神刺激时前额叶皮质激活越明显,未来发生心血管不良事件的风险越大!

心理应激是冠心病患者发生重大不良心血管事件(MACE)的危险因素。控制情绪状态和心脏生理的某些大脑区域可能参与了这种关系。前额叶皮质(rmPFC)是重要的大脑区域,处理应激并调节免疫和自主功能。情绪应

Eur J Prev Cardiol:常吃巧克力,可防冠心病!

近日,发表在《欧洲预防心脏病学杂志》上的一项系统综述和Meta分析提示,经常吃巧克力,有助于降低冠心病发生风险。